By breaking down the wall between the pre- and post-marketing phases in a medication’s life-cycle, the safety profile of new products have more time to mature in the real world.

Patient-derived reports add richness to our understanding of medicine safety not achieved by relying on healthcare professionals’ reports alone. Sten Olsson explains why.

A patient’s perspective can lead to new insights that traditional research may overlook. Yet how may we best harness their perspective to improve patient outcomes?

There is much more to pharmacovigilance than the collection of numbers and data. If we really want to create a culture of drug safety, we need to start listening to patients.

A patient’s perspective is powerful in ensuring safe medical care. Yet how may we best harness their perspective to improve patient outcomes?

COVID-19 is one of the most disruptive events in history and a threat to public health. In the rush for treatments and vaccines, how do we keep sight of the need to ensure safety?